40 likes | 65 Views
The global pharmaceutical drug delivery market is expected to reach USD 2.21 Billion by 2027, according to a new report by Reports and Data.
E N D
Pharmaceutical Drug Delivery Market To Reach USD 2.21 Billion By 2027 www.reportsanddata.com
Market Summary The global pharmaceutical drug delivery market is expected to reach USD 2.21 Billion by 2027, according to a new report by Reports and Data. Pharmaceutical drug delivery is the introduction of drugs into the body through various administration routes with its own merits and demerits. The effectiveness of a drug may substantially be influenced by way of its delivery. The development of various kinds of drug delivery systems (DDSs) has enabled improved control of toxicity, immunogenicity, pharmacodynamics, pharmacokinetics, and drug effectiveness. Growing prevalence of target conditions such as cancer, diabetes, cardiovascular diseases, respiratory diseases, and infectious diseases, among others, is a significant factor driving market growth. Cancer has a significant impact on society in the US and across the globe. It has been estimated that 1,735,350 new cancer cases were diagnosed in the US, and 609,640 people suffered death from the disease. The number of further incidences of cancer is 439.2 per 100,000 men and women annually, and the number of cancer-related morbidities is 163.5 per 100,000 men and women annually. Read More: https://www.reportsanddata.com/report-detail/pharmaceutical-drug-delivery-market www.reportsanddata.com
Market Summary Key participants include Hoffmann-La Roche Ltd., Bayer AG, GlaxoSmithKline, PLC, Becton, Dickinson and Company, Novartis AG, Antares Pharma Inc., Pfizers Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., and Amgen, among others. Route of Administration Outlook (Revenue, USD Million; 2017-2027) Oral, Injectable, Pulmonary, Topical, Nasal, Others Application Outlook (Revenue, USD Million; 2017-2027) Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Cancer, Diabetes, Others End-User Outlook (Revenue, USD Million; 2017-2027) Hospitals, Clinics, Diagnostic Centers, Others www.reportsanddata.com
About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com www.reportsanddata.com